Nownoon Fast Effective Forhead Patch

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. Each tablet is imprinted with "XYZ" on one side and "123" on the opposite side. It contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, magnesium stearate, and sodium starch glycolate. The tablets are supplied in bottles containing 100 units.

Uses and Indications

This drug is indicated for the treatment and prevention of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleansed prior to the application of the patch. The patch should be applied directly to the affected area(s).

To remove the patch, it should be gently peeled back and discarded.

Initial treatment should begin with one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. It is important to monitor for any signs of excessive dryness or peeling of the skin. If such symptoms occur, the application frequency should be reduced to once daily or every other day to mitigate these effects.

Contraindications

Use is contraindicated in individuals who are pregnant or breastfeeding unless directed by a healthcare professional. In the event of accidental ingestion resulting in an adverse reaction, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

For external use only, this product should be applied with caution. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of contact, the affected area should be flushed thoroughly with water to mitigate any potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a healthcare provider prior to use. In cases of accidental ingestion leading to an adverse reaction, immediate medical assistance should be sought, or the Poison Control Center should be contacted.

No specific laboratory tests are recommended for monitoring the use of this product. However, healthcare professionals should remain vigilant for any signs of adverse reactions and provide appropriate guidance to patients regarding the safe use of this medication.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the eyes, lips, and mouth; in the event of contact, it is recommended to flush the area thoroughly with water.

Skin irritation and dryness are common adverse reactions associated with the use of this product. The likelihood of experiencing these reactions may increase if patients concurrently use another topical acne medication. Therefore, it is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Nownoon Fast Effective Forhead Patch (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Additionally, it is important for caregivers to consult a healthcare professional if the patient is pregnant or breastfeeding before administering this medication.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to evaluate the potential risks and benefits associated with its use during pregnancy and lactation. Healthcare providers can offer guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If the substance involved is known, specific antidotes or treatments may be indicated, and healthcare professionals should refer to established guidelines for the management of overdose related to that substance.

In all cases, contacting a poison control center or a medical toxicologist for guidance is recommended to ensure appropriate management and intervention.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to consult with a healthcare professional if they are pregnant or breastfeeding before using this medication. It is important for patients to understand the potential risks and benefits associated with the use of the medication during these periods.

Additionally, healthcare providers should inform patients about the importance of seeking immediate medical assistance or contacting a Poison Control Center in the event of accidental ingestion and subsequent adverse reactions. This guidance is crucial for ensuring patient safety and appropriate management of any potential emergencies.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place, ensuring it is kept away from direct sunlight to maintain its integrity and efficacy. Proper storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

The route of administration for the medication is topical. Patients should begin with one application daily, with the option to gradually increase to two or three times daily as needed or as directed by a healthcare professional. In cases of bothersome dryness or peeling, it is recommended to reduce the application frequency to once a day or every other day.

Clinicians should counsel patients to avoid contact with the eyes, lips, and mouth, and to flush thoroughly with water if contact occurs. The likelihood of skin irritation and dryness increases if another topical acne medication is used concurrently; therefore, it is advised to use only one topical acne medication at a time if irritation arises. Pregnant or breastfeeding patients should consult a healthcare professional before use. In the event of accidental ingestion leading to an adverse reaction, patients should seek medical assistance or contact a Poison Control Center.

Drug Information (PDF)

This file contains official product information for Nownoon Fast Effective Forhead Patch, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)